Swiss National Bank’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-113,490
| Closed | -$15.5M | – | 2538 |
|
|
2020
Q3 | $15.5M | Buy |
113,490
+3,600
| +3% | +$383K | 0.01% | 665 |
|
|
2020
Q2 | $10.6M | Buy |
109,890
+24,800
| +29% | +$2.07M | 0.01% | 747 |
|
|
2020
Q1 | $3.99M | Buy |
85,090
+1,300
| +2% | +$83.3K | ﹤0.01% | 1050 |
|
|
2019
Q4 | $6.11M | Buy |
83,790
+1,400
| +2% | +$84.9K | 0.01% | 1027 |
|
|
2019
Q3 | $4.3M | Buy |
82,390
+2,500
| +3% | +$133K | ﹤0.01% | 1186 |
|
|
2019
Q2 | $4.01M | Buy |
79,890
+1,600
| +2% | +$77.9K | ﹤0.01% | 1259 |
|
|
2019
Q1 | $4.07M | Buy |
78,290
+21,500
| +38% | +$990K | ﹤0.01% | 1214 |
|
|
2018
Q4 | $2.77M | Buy |
56,790
+1,800
| +3% | +$99.1K | ﹤0.01% | 1352 |
|
|
2018
Q3 | $3.58M | Hold |
54,990
| – | – | ﹤0.01% | 1344 |
|
|
2018
Q2 | $2.73M | Buy |
54,990
+17,900
| +48% | +$867K | ﹤0.01% | 1498 |
|
|
2018
Q1 | $1.81M | Hold |
37,090
| – | – | ﹤0.01% | 1705 |
|
|
2017
Q4 | $1.56M | Hold |
37,090
| – | – | ﹤0.01% | 1790 |
|
|
2017
Q3 | $1.59M | Buy |
37,090
+5,300
| +17% | +$169K | ﹤0.01% | 1778 |
|
|
2017
Q2 | $416K | Buy |
31,790
+6,500
| +26% | +$85.6K | ﹤0.01% | 2457 |
|
|
2017
Q1 | $333K | Hold |
25,290
| – | – | ﹤0.01% | 2469 |
|
|
2016
Q4 | $328K | Buy |
+25,290
| New | +$390K | ﹤0.01% | 2504 |
|
Swiss National Bank's MYOK Position: Q4 2020 in Review
Swiss National Bank sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 113,490 shares — an estimated $15.5M sold.
Swiss National Bank first reported a position in MYOK in Q4 2016 and held it in 16 quarters. The position peaked at $15.5M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- Swiss National Bank reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- Swiss National Bank sold 113,490 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $15.5M.
- Swiss National Bank first reported a position in MyoKardia, Inc. Common Stock in Q4 2016 and held it in 16 quarters.
- Swiss National Bank's MyoKardia, Inc. Common Stock position peaked at $15.5M in Q3 2020.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on Swiss National Bank's 13F filing for Q4 2020, filed 5 Feb 2021.